000			01420 a2200349 4500
005			20250516061909.0
264		0	_c20111028
008			201110s 0 0 eng d
040			_aNLM _beng _cNLM
245	0	0	_aSpecial report: maintenance therapy in advanced non-small-cell lung cancer. _h[electronic resource]
260			_bTechnology Evaluation Center Assessment Program. Executive summary _cJul 2011
300			_a1-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBlue Cross Blue Shield Insurance Plans
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xtherapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aDisease Progression
650	0	4	_aDrug Approval
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xtherapy
650	0	4	_aOutcome and Process Assessment, Health Care
650	0	4	_aPlatinum Compounds _xadministration & dosage
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aTechnology Assessment, Biomedical
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
773	0		_tTechnology Evaluation Center Assessment Program. Executive summary _gvol. 26 _gno. 4 _gp. 1-3
999			_c21254306 _d21254306